Literature DB >> 32143612

Neferine and lianzixin extracts have protective effects on undifferentiated caffeine-damaged PC12 cells.

Jingjing Chen1,2, Mimi Tang1,2, Manhua Liu1,2, Yueping Jiang1,2, Bin Liu1,2, Shao Liu3,4.   

Abstract

BACKGROUND: The embryos of Nelumbo nucifera Gaertn seeds, lianzixin, are used in China as food and traditional herbal medicine. Principal therapeutic indications are insomnia, anxiety and pyrexia. Caffeine is a psychostimulant and excessive use predisposes to cell damage and neurotoxicity. We aimed to investigate the potential protect effect of Neferine and lianzixin extracts on undifferentiated caffeine-damaged phaeochromocytoma cells (PC12 cells).
METHODS: A cell damage model based on undifferentiated PC12 was established with caffeine. Effect of Lianzixin extracts (total alkaloids, alcohol extract and water extract) and neferine on caffeine-damaged PC12 cells was evaluated. Cell viability was assessed using the methyl thiazolyl tetrazolium (MTT) assay, cellular morphology by inverted microscope, the nucleus by Hoechst 33342 staining and cleaved poly ADP-ribose polymerase (PARP) expression by western blot analysis.
RESULTS: Lianzixin extracts (total alkaloids, alcohol extract and water extract) and neferine improved the viability of PC12 cells damaged by caffeine. The morphology of PC12 cells pretreated with neferine, or alcohol or water extract of lianzixin aggregated and attached better than caffeine-damaged cells, but cells pretreated with total alkaloids of lianzixin showed abnormal morphology. Compared with caffeine-damaged cells, cells pretreated with neferine, or alcohol or water extract of lianzixin showed a notable increase in nucleus staining and an obvious decrease in cleaved PARP expression.
CONCLUSIONS: Lianzixin extracts and neferine have protective effects against caffeine-induced damage in PC12 cells, which laid a foundation for finding a new medicine value of Lianzixin.

Entities:  

Keywords:  Alkaloid; Caffeine; Cell damage; Lianzixin; Neferine; PC12

Year:  2020        PMID: 32143612     DOI: 10.1186/s12906-020-2872-2

Source DB:  PubMed          Journal:  BMC Complement Med Ther        ISSN: 2662-7671


  2 in total

1.  The Pharmacokinetics/Pharmacodynamics and Neurotoxicity of Tigecycline Intraventricular Injection for the Treatment of Extensively Drug-Resistant Acinetobacter baumannii Intracranial Infection.

Authors:  Qi Huang; Xingwen Zhang; Aijun Jia; Qi Huang; Yu Jiang; Liangyi Xie
Journal:  Infect Drug Resist       Date:  2022-08-24       Impact factor: 4.177

2.  Evaluating the therapeutic role of selected active compounds in Plumula Nelumbinis on pulmonary hypertension via network pharmacology and experimental analysis.

Authors:  Xinghua Xiao; Fangmei Luo; Minyi Fu; Yueping Jiang; Shao Liu; Bin Liu
Journal:  Front Pharmacol       Date:  2022-08-17       Impact factor: 5.988

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.